Zylox-Tonbridge Medical Technology Co., Ltd. (FRA:818)

Germany · Delayed Price · Currency is EUR

2.120

0.00 (0.00%)

Last updated: Oct 23, 2026, 9:55 AM CEST

Market Cap	735.71M -15.5%
Revenue (ttm)	155.60M +34.4%
Net Income	39.29M +99.8%
EPS	0.13 +105.5%
Shares Out	n/a
PE Ratio	16.90
Forward PE	14.36
Dividend	0.03 (1.30%)
Ex-Dividend Date	May 27, 2026

Volume	15
Open	2.120
Previous Close	2.120
Day's Range	2.120 - 2.120
52-Week Range	1.880 - 2.980
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 20, 2026

About FRA:818

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. The company’s peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as cove... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2012

Employees 1,214

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 818

Financial Performance

In 2025, FRA:818's revenue was 1.06 billion, an increase of 35.15% compared to the previous year's 782.48 million. Earnings were 244.37 million, an increase of 143.75%.

Financial numbers in CNY Financial Statements